OpenVSafe by OpenVAERS
Search V-safe

C3K-10715-63046

3 vaccinations 5 coded responses 27 check-ins 3 free-text entries 0 call cases
Sex
Male
Age at first dose
0-4
ZIP prefix
605 / IL
Registered
2022-10-12
Relationship
Child or adolescent in my care
Guardian
A7W-23974-46760
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-09-21
    Dose 1 — Pfizer-BioNTech
  2. 2022-10-12
    Registered in v-safe
  3. 2022-10-12
    Dose 2 — Pfizer-BioNTech
  4. 2022-10-12
    Health check-in — day 0, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-10-13
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-10-14
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-10-15
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · None
    Under 3 check-in
  8. 2022-10-16
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-10-17
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · Irritability/crying
    Under 3 check-in
  10. 2022-10-18
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  11. 2022-10-19
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  12. 2022-10-26
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  13. 2022-11-02
    Survey response — day 21, dose 2, under 3
    MedDRA: Cough, Hypersomnia, Irritability, Nasopharyngitis, Rhinorrhoea, Unevaluable event — Feeling: Good
    Free text: cold symptoms: runny nose, cough, fussiness, rubbing eyes and nose, more sleep
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-11-11
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  15. 2022-11-16
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  16. 2022-11-23
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  17. 2022-12-07
    Dose 3 — Pfizer-BioNTech
  18. 2022-12-08
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  19. 2022-12-09
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  20. 2022-12-10
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  21. 2022-12-11
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  22. 2022-12-12
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  23. 2022-12-13
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  24. 2022-12-16
    Health check-in — day 7, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  25. 2022-12-21
    Survey response — day 14, dose 3, under 3
    MedDRA: Cough — Feeling: Fair
    Free text: Cough
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-12-28
    Survey response — day 21, dose 3, under 3
    MedDRA: Rhinorrhoea — Feeling: Fair
    Free text: Runny nose
    MedDRA releases: 2024-11 · check-in free text available
  27. 2023-01-04
    Health check-in — day 28, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  28. 2023-01-11
    Health check-in — day 35, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  29. 2023-01-18
    Survey response — day 42, dose 3, under 3
    MedDRA: Cough, Decreased appetite, Fatigue, Irritability, Nasopharyngitis, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activities
    MedDRA releases: 2024-11
  30. 2023-03-09
    Survey response — 3 months, dose 3, under 3
    MedDRA: Cough, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school
    MedDRA releases: 2024-11
  31. 2023-06-07
    Health check-in — 6 months, dose 3, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-09-21Pfizer-BioNTech No
22022-10-12Pfizer-BioNTech No
32022-12-07Pfizer-BioNTech No

Free text

Release 12 (Under 3) — day 21, dose 2, under 3

2022-11-02

Symptoms: cold symptoms: runny nose, cough, fussiness, rubbing eyes and nose, more sleep

Release 12 (Under 3) — day 14, dose 3, under 3

2022-12-21

Symptoms: Cough

Release 12 (Under 3) — day 21, dose 3, under 3

2022-12-28

Symptoms: Runny nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDDecreased appetite · · ✓
SDFatigue · · ✓
SDHypersomnia · · ✓
SDIrritability · · ✓
SDNasopharyngitis · · ✓
SDPyrexia · · ✓
SDRhinorrhoea · · ✓
SDUnevaluable event · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…